Peptide Therapy Insights

New Technique Enhances Peptide Therapeutics with Non-Natural Amino Acids

A groundbreaking technique now enables the synthesis of non-natural amino acids, potentially revolutionizing peptide therapeutics. Learn how this could impact treatment options.

Optimizing Chromatography for Peptide Purification: Key Insights

Discover how advancements in chromatography optimization are enhancing the purification of therapeutic peptides. This could impact the quality and availability of peptide therapies for patients.

FDA Implements New Restrictions on Mass-Marketed Compounded GLP-1 Products

Injectable Peptide Therapy Gains Mainstream Acceptance in 2025

GLP-1 Market Growth Projected to Hit $33.26 Billion by 2030: Implications for Obesity and Diabetes Therapies

Semaglutide vs. Tirzepatide Side Effects: Complete Head-to-Head Comparison (2026)

Comprehensive comparison of semaglutide (Wegovy) and tirzepatide (Zepbound) side effects, including nausea rates, GI tolerability, FDA status, cost, and how to choose between them.

Novartis and Unnatural Collaborate on Innovative Macrocyclic Peptide Therapies

Peptide Therapy: Balancing Hope with Scientific Evidence

Novartis Secures Licensing Agreement with UNP for Advanced Peptide Therapeutics